Novo Nordisk’s diabetes drug sales slow sharply

All NewsAugust 6, 2025

Danish group loses market share to rivals, with first-half growth easing to 8%

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent